Effectiveness of a Guided Self-help Intervention for Improving Sleep in University Students

September 4, 2023 updated by: Philip Spinhoven, Leiden University Medical Center

A Study on the Effectiveness of a Guided E-health Sleep and Biological Clock Intervention in University Students (i-Sleep & BioClock)

This randomized controlled trials aims to assess the effectiveness of an online guided self-help intervention ('i-Sleep & BioClock') based on CBTi principles for university students' sleep problems. The study will involve 192 students with subthreshold insomnia who will be randomized to the intervention or online psychoeducation. The intervention consists of 5 modules completed in about 5 weeks, supported by e-coaches. Outcomes include insomnia severity, mental health symptoms, functioning, quality of life, and academic performance, measured at baseline, post-treatment (6 weeks after baseline), and 18 weeks follow-up.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Rationale: University students often suffer from sleep problems which affect their mental health and daily functioning. Cognitive behavioural therapy for insomnia (CBTi) has been proven effective in adults, but research in university students is still limited. The investigators hypothesize that a guided e-health self-help intervention based on CBTi principles ('i-Sleep & BioClock') could offer convenient treatment to students with sleep problems by reducing insomnia severity and improving mental health outcomes.

Objective: The aim of this randomized controlled trial is to assess the effectiveness of a guided e-health sleep and biological clock intervention on sleep, mental health symptoms (depression and anxiety), functioning, quality of life, and academic performance in university students.

Study design: This is a two-arm parallel group superiority randomized controlled trial, comparing a guided e-health intervention based on CBTi to online psychoeducation (PE).

Study population: The aim is to include 192 university students (Bachelor, Master and PhD) with at least subthreshold insomnia (Insomnia Severity Index ≥ 10), aged ≥ 16, who are able to speak Dutch or English, and are affiliated to one of the nine participating universities. Students with current suicidal ideation are excluded.

Intervention: The intervention will be a guided e-health intervention based on CBTi principles (i-Sleep & BioClock). It consists of 5 modules, to be completed in about 5 weeks, and is aimed at improving sleep in university students. The intervention will be entirely held online and will be supported by e-coaches.

Main study parameters/endpoints: The primary outcome will be insomnia severity. Secondary outcomes will be depression, anxiety, daily functioning, academic performance, quality of life, and sleep & light exposure diary outcomes. Outcomes will be measured at baseline, at post-treatment (6 weeks after baseline), and at 18 weeks follow-up. Mediators such as shift in chronotype and light exposure will be examined at baseline, mid-treatment, and post-treatment

Study Type

Interventional

Enrollment (Estimated)

192

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being fluent in Dutch and/or English
  • Being enrolled as a student (Bachelor, Master or PhD) in one of the Caring Universities partner universities
  • Being ≥ 16 years old
  • Having self-reported sleep problems; Insomnia Severity Index ≥ 10

Exclusion Criteria:

  • Regular night shifts (Not being able to comply to the intervention due to regular night shift, meaning work between 2AM and 6AM at least once a week)
  • Current risk for suicidal behaviour

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Guided online self-help intervention
The intervention will be a guided e-health intervention based on CBTi principles (i-Sleep & BioClock). It consists of 5 modules, to be completed in about 5 weeks, and is aimed at improving sleep in university students. The intervention will be entirely held online and will be supported by e-coaches. The topics covered will be sleep hygiene, psychoeducation on sleep and the biological clock, sleep restriction, stimulus control, worrying and relaxation, dysfunctional thoughts, and relapse prevention.
Module 1 Psychoeducation about normal sleep and insomnia, Psychoeducation on the biological clock: the circadian rhythm, chronotypes, zeitgebers, importance of light behaviour Basic sleep hygiene: information about behaviours that are known to promote or impede sleep e.g. performing physical exercise or the use of caffeine Module 2 Sleep restriction and stimulus control: patients are taught to use the bedroom only to sleep and to restrict the time in bed to the average amount of night-time sleep Module 3 Worrying and relaxation: audio files with progressive muscle relaxation exercises are offered and techniques to stop worrying (e.g. thought blocking, evaluation and worry time) Module 4 Erroneous cognitions about sleep: the basics of cognitive behavioural therapy are explained and the most common erroneous ideas about insomnia are discussed Module 5 Summary and plan for the future
Active Comparator: Online psychoeducation
The control group will receive access to the platform and to the sleep diary. Their intervention will consist of brief, unstructured online PE for insomnia based on recognized sleep hygiene advice, for example, recommendations about evening routines, and use of alcohol and caffeine. Students will be advised to monitor their sleep in the diary. In contrast to the intervention group, the control group will not receive support of an e-coach. Key differences to the CBTi group are that the online PE (1) does not provide individualized support by an e-coach; (2) includes less content, and (3) is not delivered in a step-by-step manner, but will be provided all at once.
Online psychoeducation about sleep and the biological clock, basic sleep hygiene

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Insomnia Severity Index
Time Frame: Baseline (T0), 3 weeks after baseline (T1), 6 weeks after baseline (T2), and 18 weeks after baseline (T3)
7-item self-report instrument to assess insomnia severity, scores 0-28, higher scores indicating more insomnia severity
Baseline (T0), 3 weeks after baseline (T1), 6 weeks after baseline (T2), and 18 weeks after baseline (T3)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep efficiency (in minutes)
Time Frame: Change from week 1 to week 7
Derived from sleep and light exposure diary
Change from week 1 to week 7
Sleep onset latency (in minutes)
Time Frame: Change from week 1 to week 7
Derived from sleep and light exposure diary
Change from week 1 to week 7
Wake after sleep onset (in minutes)
Time Frame: Change from week 1 to week 7
Derived from sleep and light exposure diary
Change from week 1 to week 7
Early morning awakening (in minutes)
Time Frame: Change from week 1 to week 7
Derived from sleep and light exposure diary
Change from week 1 to week 7
Total sleep time (in minutes)
Time Frame: Change from week 1 to week 7
Derived from sleep and light exposure diary
Change from week 1 to week 7
Time spent outside (in minutes)
Time Frame: Change from week 1 to week 7
Derived from sleep and light exposure diary
Change from week 1 to week 7
Screen use before bed
Time Frame: Change from week 1 to week 7
Yes/ No question. Derived from sleep and light exposure diary
Change from week 1 to week 7
Munich Chronotype Questionnaire (MCTQ)
Time Frame: Baseline (T0), 6 weeks after baseline (T2), and 18 weeks after baseline (T3)
Self-rated scale to assess individual phase of entrainment on work and work-free days, Addresses questions about: bedtime (actual time), time spent in bed awake before deciding to turn off the lights (in minutes), how long it takes to fall asleep (in minutes), wake up time (actual time), get up time (actual time) on work and work-free days. MCTQ uses the midpoint between sleep on- and offset on free days (mid-sleep on free days, MSF) to assess chronotype. The MCTQ chronotype is expressed in local time, in which earlier time refers to earlier chronotype and later time to later chronotype.
Baseline (T0), 6 weeks after baseline (T2), and 18 weeks after baseline (T3)
Patient Health Questionnaire (PHQ-9)
Time Frame: Baseline (T0), 6 weeks after baseline (T2), and 18 weeks after baseline (T3)
9-items self-report instrument for severity of depressive symptoms, scores ranging from 0-27, higher scores indicating more severe depression
Baseline (T0), 6 weeks after baseline (T2), and 18 weeks after baseline (T3)
Generalised Anxiety Disorder scale (GAD-7)
Time Frame: Baseline (T0), 6 weeks after baseline (T2), and 18 weeks after baseline (T3)
7-items self-report instrument for severity of anxiety symptoms, scores ranging from 0-21, higher scores indicating more severe anxiety
Baseline (T0), 6 weeks after baseline (T2), and 18 weeks after baseline (T3)
Work and Social Adjustment Scale (WSAS)
Time Frame: Baseline (T0), 6 weeks after baseline (T2), and 18 weeks after baseline (T3)
5-item self-report instrument for impairment of functioning, scores ranging from 0-40, higher scores indicating more impairment in functioning
Baseline (T0), 6 weeks after baseline (T2), and 18 weeks after baseline (T3)
Mental Health Quality of Life questionnaire (MHQoL)
Time Frame: Baseline (T0), 6 weeks after baseline (T2), and 18 weeks after baseline (T3)
7-item self report instrument for quality of life measure for use in people with mental health problems, scores ranging from 0-21, higher scores indicating higher quality of life, and MHQoL-VAS visual scale ranging from 0 (worst imaginable psychological wellbeing) to 10 (best imaginable psychological wellbeing)
Baseline (T0), 6 weeks after baseline (T2), and 18 weeks after baseline (T3)
Dysfunctional beliefs and attitudes about sleep (DBAS-10)
Time Frame: Baseline (T0), 3 weeks after baseline (T1), 6 weeks after baseline (T2)
10-item abbreviated measure for dysfunctional beliefs and attitudes about sleep, scored on a scale from 0 (strongly disagree) to 10 (strongly agree)
Baseline (T0), 3 weeks after baseline (T1), 6 weeks after baseline (T2)
Pre-Sleep Arousal Scale (PSAS)
Time Frame: Baseline (T0), 3 weeks after baseline (T1), 6 weeks after baseline (T2)
16-item self report instrument for pre-sleep arousal, 5-point Likert Scale, higher scores reflecting more arousal
Baseline (T0), 3 weeks after baseline (T1), 6 weeks after baseline (T2)
Academic performance
Time Frame: Baseline (T0), 6 weeks after baseline (T2), and 18 weeks after baseline (T3)
Students will be asked about the grade of their last exam (Scale 1-10), the average grade of the past semester (Scale 1-10), whether they failed any exams in the past semester (Yes/No), and their study progression in the past semester in terms of ECTS achieved (30 ECTS per semester, Yes/No)
Baseline (T0), 6 weeks after baseline (T2), and 18 weeks after baseline (T3)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence - Total number of completed modules
Time Frame: Through study completion, an average of 18 weeks
Measures though Log Data
Through study completion, an average of 18 weeks
Adherence - Time spent in the platform (in minutes)
Time Frame: Through study completion, an average of 18 weeks
Measures though Log Data
Through study completion, an average of 18 weeks
Adherence - Number of logins (total amount)
Time Frame: Through study completion, an average of 18 weeks
Measures though Log Data
Through study completion, an average of 18 weeks
Adverse events
Time Frame: Mid-treatment (T1), 6 weeks after baseline (T2), and 18 weeks after baseline (T3)
1) falling accidents, 2) traffic accidents, or 3) any other accidents related to fatigue or sleepiness, and its consequences
Mid-treatment (T1), 6 weeks after baseline (T2), and 18 weeks after baseline (T3)
Stressful life events questionnaire
Time Frame: Baseline (T0), 3 weeks after baseline (T1), 6 weeks after baseline (T2), and 18 weeks after baseline (T3)
2 item questionnaire about whether participants experienced life-threatening or serious accident/ illness, death of someone close, physical/sexual violence or abuse or other incidents, and the consequences thereof
Baseline (T0), 3 weeks after baseline (T1), 6 weeks after baseline (T2), and 18 weeks after baseline (T3)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Niki Antypa, Dr., Leiden University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2023

Primary Completion (Estimated)

October 1, 2024

Study Completion (Estimated)

October 1, 2024

Study Registration Dates

First Submitted

August 3, 2023

First Submitted That Met QC Criteria

September 4, 2023

First Posted (Actual)

September 5, 2023

Study Record Updates

Last Update Posted (Actual)

September 5, 2023

Last Update Submitted That Met QC Criteria

September 4, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • i-Sleep&BioClockRCT

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Insomnia

Clinical Trials on i-Sleep & BioClock

3
Subscribe